CategoryMedical & Pharma
International Transplant Nurses Society - ITNS
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to International Transplant Nurses Society - ITNS — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
International Transplant Nurses Society (ITNS) — ITNS Event Description (TTS 2026)
The International Transplant Nurses Society (ITNS) is represented through the 31st International Congress of The Transplantation Society (TTS 2026), a major global scientific and professional gathering focused on transplantation medicine and patient impact. This four-day congress is scheduled to take place from September 20–23, 2026 in Sydney, Australia.
The congress is designed to bring together a wide range of stakeholders across the transplantation ecosystem—including clinicians, scientists, trainees, and allied health professionals—to advance clinical practice and research. The organizing collaboration for TTS 2026 highlights the partnership between The Transplantation Society and Transplantation Society of Australia and New Zealand (TSANZ), reinforcing both international reach and local scientific leadership.
Why this event matters
TTS 2026 is presented as a landmark platform for scientific exchange, professional development, and international collaboration. The congress emphasizes a core shared mission: to improve the lives of patients in need of life-saving transplants. Across sessions, attendees are expected to explore the latest developments in transplantation through education-forward programming and expert-led knowledge sharing.
What attendees can expect
Over the duration of the congress, participants will be engaged through a structured program that includes:
- State-of-the-art lectures and plenary sessions
- Workshops designed for deeper learning and application
- Oral presentations and poster sessions supporting scientific communication and discussion
- Affiliated program components that further strengthen networking and professional exchange
Audience and attendee profile
The event’s audience is positioned as highly international and multidisciplinary. The official congress description states that the meeting will bring together over 3,000 participants from across the globe, reflecting a mix of:
- Clinicians involved in transplant care and related specialties
- Scientists working on transplantation research
- Trainees developing expertise within transplantation fields
- Allied health professionals contributing essential multidisciplinary perspectives
In addition, The Transplantation Society is described as representing over 5,000 members from 105 countries, which reinforces that TTS 2026 is built for cross-border knowledge exchange and international professional networking.
Congress chair and leadership messaging
The official website includes leadership messaging from the congress chair and president, along with congress co-chair and committee leadership roles from multiple countries. This structure indicates a coordinated scientific and educational mission supported by a global network of professionals and committee members.
Confirmed timing and important dates (from the official site)
While the congress takes place in September 2026, the official website also highlights key milestones for participation:
- Abstract submissions open: January 2026
- Abstract submission deadline: March 19, 2026 (23:59 EST)
- Awards application deadline: April 25, 2026
- Abstract notification distributed: May 25–26, 2026
- Awards notification: June 5, 2026
- Early-bird registration deadline: June 23, 2026
Registration and venue city
The congress is scheduled in Sydney, Australia from September 20–23, 2026. Further venue and registration details are available through the congress materials and site sections dedicated to registration, accommodation, visas and entry, and congress venue information.
Member and professional value (ITNS fit)
For ITNS-aligned professionals, this congress setting supports knowledge advancement across transplantation practice and care delivery. With programming spanning lectures, workshops, scientific presentations, and structured professional exchanges, TTS 2026 serves as a strong environment to connect transplant nursing and allied health perspectives with broader clinical and research developments in transplantation.
Data sheet
31st International Congress of The Transplantation Society (TTS 2026) – Event Attendee & Buyer Profile Analysis
Event date: September 20–23, 2026 |
Location: Sydney, Australia |
Event status: Upcoming |
Research date: July 1, 2026
Note: The official website content provided identifies this event as the 31st International Congress of The Transplantation Society (TTS 2026) in Sydney, Australia. This report uses the official event identity reflected on the primary source.
Event Overview
| Event Name | 31st International Congress of The Transplantation Society (TTS 2026) |
| Event Date | September 20–23, 2026 |
| Event Status | Upcoming |
| Venue | Congress Venue not specified in the provided official website text |
| City | Sydney |
| State / Region | New South Wales |
| Country | Australia |
| Organizer | The Transplantation Society, in partnership with the Transplantation Society of Australia and New Zealand (TSANZ) |
| Official Event Website | tts2026.org |
| Event Type | International scientific congress / medical conference |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness; Business Services |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | Over 3,000 participants mentioned by the organizer |
| Attendance Data Reliability | Confirmed on official website for this edition |
| Main Purpose of Event | Scientific exchange, professional development, and collaboration to advance transplantation practice and improve patient outcomes |
About the Event
TTS 2026 is the 31st International Congress of The Transplantation Society, a major global meeting focused on transplantation medicine, research, education, and clinical practice. The congress is scheduled for September 20–23, 2026 in Sydney, Australia and is positioned as a high-level scientific forum for clinicians, scientists, trainees, and allied health professionals.
The event matters because it convenes an international transplant community around patient care, surgical innovation, immunology, organ allocation, and best-practice advancement. For B2B suppliers, the congress offers access to highly specialized healthcare decision-makers, research leaders, clinical department heads, and hospital procurement stakeholders involved in transplant-related technologies, devices, diagnostics, education, and services.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Transplant surgeons and surgical department leaders | Hospitals, transplant centers, academic medical centers | Clinical influence, product specification, protocol adoption | Key decision-makers for surgical tools, monitoring systems, and procedure support services |
| Transplant nurses and nurse managers | Hospitals, transplant units, dialysis and post-op care teams | Workflow influence, clinical evaluation, care coordination | Important for education, training, patient monitoring, and care pathway solutions |
| Transplant physicians and nephrologists | Hospitals, specialty clinics, university medical centers | Clinical decision-making and treatment protocol leadership | Relevant for diagnostics, drugs, clinical software, and post-transplant care products |
| Allied health professionals | Rehabilitation, social work, pharmacy, nutrition, case management teams | Program influence and patient-support workflow input | Relevant for patient engagement, medication adherence, logistics, and support services |
| Researchers and laboratory scientists | Universities, research institutes, hospital labs | Research funding, methods selection, technology evaluation | Relevant for reagents, lab technologies, clinical trials, and data tools |
| Hospital procurement and supply chain teams | Hospitals, health systems, group purchasing organizations | Vendor onboarding, contract negotiation, purchasing approval | Important for medtech, consumables, IT systems, and service providers |
| Clinical operations and program managers | Transplant programs, hospitals, academic centers | Implementation and operational decision-making | Strong fit for workflow software, scheduling, tracking, and service solutions |
| Pharmaceutical and immunology stakeholders | Pharma companies, biotech firms, medical affairs teams | Scientific engagement, market access, partnership development | Relevant for immunosuppressants, biomarkers, and transplant-related therapies |
| Professional association and society leaders | Medical societies, specialty associations, training bodies | Program partnership, education, sponsorship, advocacy | Useful for conference services, publishing, education, and event solutions |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Sydney metro | High | Medium | Strong concentration of major hospitals, universities, and medical networks |
| New South Wales and nearby states | High | High | Likely domestic attendance from hospitals, universities, and medical suppliers |
| Other major Australian medical hubs | Medium to high | High | Melbourne, Brisbane, Adelaide, Perth, Canberra likely represented |
| Asia-Pacific region | Medium to high | High | Australia’s regional connectivity supports attendance from New Zealand and Asia-Pacific transplant centers |
| North America and Europe | Medium | Medium to high | Global scientific congress likely to attract international experts and sponsors |
| Global transplant community | High for specialist segments | High | The organizer states TTS represents over 5,000 members from 105 countries |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary | Official site describes TTS as a global organization with members from 105 countries; the congress is positioned as an international transplant meeting. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| The Transplantation Society (TTS) | Association / host organization | Organizer and core ecosystem stakeholder for transplant education and partnerships | tts.org | Executive Director, Meetings Director, Education Director | Confirmed Speaker Organization |
| Transplantation Society of Australia and New Zealand (TSANZ) | Association / partner | Official partnering society for the Sydney congress | tsanz.com.au | President, Board Member, Events Manager | Confirmed Speaker Organization |
| University of Sydney | Academic medical center | Likely transplant research and clinical education stakeholder in Sydney | sydney.edu.au | Head of Transplant Program, Research Director, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| Royal Prince Alfred Hospital | Hospital / transplant center | Major Sydney clinical institution relevant to transplant care | slhd.nsw.gov.au | Transplant Director, Nursing Manager, Supply Chain Lead | Strong Market Fit, Attendance Not Confirmed |
| St Vincent’s Hospital Sydney | Hospital / clinical buyer | Relevant transplant, nephrology, and surgical services stakeholder | svhs.org.au | Clinical Director, Procurement, Nursing Unit Manager | Strong Market Fit, Attendance Not Confirmed |
| Monash Health | Health system | Large tertiary health network with procurement and transplant-related care influence | monashhealth.org | Procurement Director, Operations Director, Specialist Unit Manager | Strong Market Fit, Attendance Not Confirmed |
| The Royal Melbourne Hospital | Hospital / academic center | Transplant and specialty care stakeholder; likely B2B buyer for clinical solutions | thermh.org.au | Department Head, Procurement Manager, Clinical Nurse Consultant | Strong Market Fit, Attendance Not Confirmed |
| Fresenius Medical Care | Medtech / renal care supplier | Relevant to kidney care ecosystem, procurement, and clinical partnerships | freseniusmedicalcare.com | Business Development Director, Medical Affairs, Partnerships | Strong Market Fit, Attendance Not Confirmed |
| Baxter International | Medical technology / pharmaceuticals | Supplier to renal, hospital, and perioperative environments | baxter.com | Regional Sales Director, Medical Affairs, Strategic Accounts | Strong Market Fit, Attendance Not Confirmed |
| Takeda | Pharmaceutical company | Potential stakeholder in immunology and transplant-related therapy ecosystem | takeda.com | Medical Science Liaison, Market Access, Congress Manager | Strong Market Fit, Attendance Not Confirmed |
| Novartis | Pharmaceutical company | Relevant to immunosuppression, clinical education, and healthcare partnerships | novartis.com | Medical Affairs Director, Brand Lead, Partnerships Manager | Strong Market Fit, Attendance Not Confirmed |
| Astellas Pharma | Pharmaceutical company | Transplant-relevant therapeutic and medical education stakeholder | astellas.com | Medical Affairs, Congress Planning, Commercial Operations | Strong Market Fit, Attendance Not Confirmed |
| ISHLT | Medical society | Closely adjacent transplant society with highly relevant audience overlap | ishlt.org | Society Executive, Programs Manager, Sponsorship Lead | Strong Market Fit, Attendance Not Confirmed |
| UNSW Sydney | University / research institution | Likely transplant and biomedical research stakeholder in the host city | unsw.edu.au | Research Director, Faculty Lead, Grants Manager | Strong Market Fit, Attendance Not Confirmed |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer / Clinical Director | Clinical Leadership | C-level / VP | Sets clinical direction and approves strategic vendor relationships |
| 2 | Head of Transplant Program | Transplant Services | Director / Head | Primary clinical owner for transplant workflow, tools, and partnerships |
| 3 | Transplant Surgeon | Surgery | Senior | Influences device selection, procedural standards, and clinical adoption |
| 4 | Nephrology Lead / Consultant Nephrologist | Nephrology | Senior | Often involved in patient pathway decisions and clinical therapy discussions |
| 5 | Transplant Nurse Manager | Nursing | Manager / Senior Manager | Strong influence on workflow, training, and care delivery tools |
| 6 | Procurement Manager / Strategic Sourcing Manager | Procurement | Manager | Evaluates vendors, pricing, and contracting for hospital purchases |
| 7 | Supply Chain Director | Supply Chain | Director | Relevant for product availability, logistics, and vendor management |
| 8 | Clinical Research Director | Research | Director | Drives adoption of research platforms, trials, and data solutions |
| 9 | Medical Affairs Director | Medical Affairs | Director | Key for pharma and biotech engagement |
| 10 | Program Manager / Operations Manager | Operations | Manager | Coordinates event-related or clinical service implementation |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core industry for transplant care and hospital-based buyers | Clinical, procurement, and operations targeting |
| 2 | Medical Devices | Relevant to transplant procedures, monitoring, and surgical tools | Device buyers and clinical adopters |
| 3 | Pharmaceuticals | Transplant medicine depends on immunology and drug management | Medical affairs, market access, and congress teams |
| 4 | Biotechnology | Research and therapeutic innovation relevance | R&D collaborations and translational research |
| 5 | Research | Scientific congress attracts researchers and clinical investigators | Data, trials, and study management tools |
| 6 | Information Technology & Services | Health IT, workflow, and analytics use cases are relevant | Clinical software, data platforms, integration services |
| 7 | Biotechnology Research | Research-heavy audience and translational medicine relevance | Lab, trial, and data solutions |
| 8 | Government Administration | Public health systems and regulatory stakeholders may attend | Public sector outreach |
| 9 | Logistics & Supply Chain | Relevant to hospital inventory, cold chain, and distribution | Supply chain software and services |
| 10 | Education Management | Congress includes professional development and training | CME, learning platforms, training services |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Over 3,000 participants | Confirmed | Official website welcome message | Organizer states the congress will bring together over 3,000 participants |
| Exhibitor count | Not publicly confirmed | Unconfirmed | Official website does not provide a count in the supplied text | Exhibitor Manual exists, but count not stated |
| Buyer count | Not publicly confirmed | Unconfirmed | Organizer does not publish buyer-side attendance numbers in the supplied text | Likely mostly clinician and research delegates |
| Speaker count | Up to 1,000 oral presentations planned | Confirmed | Official website quicklinks | This is not the same as total speakers, but indicates a large scientific program |
| Sponsor count | Confirmed sponsors page available | Confirmed page, count not stated | Official website navigation | Sponsor roster should be reviewed on the official site for current-year names |
| Historical attendance | Attendance figure not publicly confirmed by the organizer for prior editions in the supplied text | Not available in provided official text | Official website content provided | Use only confirmed current-year attendance statement above |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Transplant clinical care | Improved patient outcomes, protocols, and monitoring | Engage clinicians with evidence-based product value | Clinical devices, patient monitoring, care pathway solutions |
| Research and innovation | Access to studies, data, and translational tools | Position solutions for research productivity and evidence generation | Lab tools, analytics, trial software, data platforms |
| Education and training | Professional development and knowledge transfer | Offer CME, workshops, and learning content | Training platforms, educational services, content development |
| Hospital procurement | Reliable supply, pricing, compliance, contracting | Meet supply chain and procurement leaders for buying cycles | Consumables, service contracts, procurement software |
| Pharma and therapeutics | Therapy awareness, physician engagement, medical affairs support | Sponsor sessions and medical education partnerships | Pharma communications, patient support, congress support |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | Strong concentration of clinical, research, and hospital decision-makers |
| Decision-maker availability | High | Likely presence of senior physicians, program heads, and association leaders |
| Data collection potential | Medium | Official participant list not provided in supplied text; agenda and sponsor pages are useful |
| Apollo targeting potential | Very High | Excellent fit for healthcare, medical devices, pharma, and research-based prospecting |
| Geographic targeting potential | High | Australia, APAC, North America, and Europe can be targeted cleanly |
| Best outreach approach | Direct, specialized, educational | Use clinical-value messaging, peer credibility, and research alignment |
| Overall lead quality | Very High | Specialist congress with high-value, niche buyers and strong professional intent |
| Best use case | List building and account targeting | Ideal for attendee intelligence, sponsorship outreach, and healthcare account prospecting |
| Limitations / risks | No current-year attendee list in provided text | Buyer company names beyond official host/partner organizations are not confirmed by the event source |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Devices; Pharmaceuticals; Biotechnology; Research; Information Technology & Services; Government Administration; Logistics & Supply Chain; Education Management | Targets the most relevant institutional buyers and clinical stakeholders |
| Departments | Procurement; Supply Chain; Clinical Operations; Nursing; Surgery; Research; Medical Affairs; Partnerships; Business Development | Aligns with buying, influence, and budget-owning functions |
| Seniority | Manager, Director, VP, CXO, Head, Principal | Prioritizes decision-makers and senior influencers |
| Job titles | Transplant Director, Procurement Manager, Nursing Manager, Clinical Director, Head of Surgery, Medical Affairs Director, Research Director, Supply Chain Director | Focuses on functions likely to attend or influence purchase decisions |
| Geography | Australia; New Zealand; Singapore; Japan; South Korea; United States; Canada; United Kingdom; Germany; Netherlands | Covers likely domestic and international transplant ecosystems |
| Employee size | 201–5000+ employees | Hospitals, medtech firms, and universities often fall into these ranges |
| Keywords | transplant, organ, nephrology, immunology, surgery, post-transplant, dialysis, graft, donor, clinical research | Improves relevance for specialized healthcare accounts |
| Company type | Hospitals, academic medical centers, pharma, medtech, research institutes, associations | Matches the attendee ecosystem and buyer universe |
| Revenue range | Mid-market to enterprise | Useful for medtech, pharma, and hospital system targeting |
Suggested Apollo Search Logic: (Hospital & Health Care OR Medical Devices OR Pharmaceuticals OR Biotechnology) AND (transplant OR nephrology OR immunology OR surgery OR clinical research) AND (Director OR VP OR Head OR Manager OR Chief) AND geography in Australia, New Zealand, APAC, United States, Canada, UK, or EU healthcare hubs.
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| TTS 2026 Official Website | Official organizer website | Event name, dates, city, country, organizer context, attendance estimate, program scale, sponsor/exhibitor navigation | Very High |
| The Transplantation Society | Organizer / association website | Organizer identity and global transplant society context | High |
| Transplantation Society of Australia and New Zealand | Partner organization website | Local host partnership context and regional relevance | High |
| Official website navigation: Confirmed Sponsors / Exhibitor Manual / Program / Registration & Hotel | Official site sections | Event commercial and attendee ecosystem structure | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to International Transplant Nurses Society - ITNS — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds